Measles Is Rising Worldwide in 2026: What the Global Surge Means for U.S. Families

Bottom line: Measles cases are rising again across multiple regions of the world in 2026. Because measles spreads easily through international travel, outbreaks abroad can quickly affect U.S. communities—especially where vaccination rates have slipped. Two doses of the MMR vaccine remain the most reliable protection.

Global measles cases are climbing again

Recent updates from the World Health Organization (WHO) and regional health agencies show a sustained increase in measles activity across parts of Africa, Europe, the Eastern Mediterranean, and the Americas. WHO has repeatedly warned that measles outbreaks are expanding in countries where routine childhood vaccination coverage has not fully recovered after COVID-19 disruptions.

Measles is not new—but its return at this scale signals widening immunity gaps. WHO notes that even small declines in vaccination coverage can trigger outbreaks because measles is one of the most contagious viruses known.

In the Americas, the Pan American Health Organization (PAHO) has reported renewed transmission in several countries, increasing the risk of imported cases into the United States. The U.S. Centers for Disease Control and Prevention (CDC) continues to monitor domestic cases, most of which are linked to international travel or spread in undervaccinated communities.

Why measles is resurging

Public health agencies point to several overlapping drivers:

Declines in routine childhood immunization: During the COVID-19 pandemic, many children missed well-child visits and vaccinations.
Health system strain: Ongoing workforce shortages and limited access to care have slowed catch-up vaccination in some regions.
Conflict and displacement: War, migration, and humanitarian crises disrupt vaccine delivery and crowd people into high-risk settings.
Misinformation: False claims about vaccine safety continue to undermine confidence in some communities.

No single factor explains the surge. Measles tends to rebound wherever vaccination coverage drops below the level needed for community protection—about 95% for this virus.

Why measles spreads so easily

Measles spreads through the air when an infected person breathes, coughs, or sneezes. According to WHO and CDC guidance:

The virus can linger in the air for up to two hours after a person leaves a room.
People are contagious about four days before the rash appears and four days after.
Up to 9 out of 10 unvaccinated people exposed will become infected.

Because people can spread measles before they know they are sick, it can move quickly through schools, childcare centers, airports, and healthcare settings.

Symptoms and serious complications

Measles usually begins with:

High fever (often 103–105°F)
Cough
Runny nose
Red, watery eyes
A red rash that starts on the face and spreads downward

While many children recover, measles can cause serious complications. WHO reports that pneumonia is the most common cause of measles-related death in young children. Other risks include:

Encephalitis (brain swelling), which can lead to seizures or long-term disability
Severe dehydration from diarrhea
Subacute sclerosing panencephalitis (SSPE), a rare but fatal brain disease that can appear years after infection
Pregnancy complications, including miscarriage or premature birth

Who is most at risk

The highest-risk groups include:

Infants too young to receive the full MMR series
Unvaccinated children and adults
People with weakened immune systems
Pregnant people without evidence of immunity

These groups depend on high community vaccination coverage for protection.

What this means for U.S. travelers and schools

In the United States, most measles cases are linked to international travel. Someone can become infected abroad, return home while contagious, and expose others before a rash appears.

The CDC advises that travelers be fully vaccinated before international trips. Infants 6–11 months old traveling internationally should receive one early dose of MMR (this does not replace the routine two-dose series).

Schools and childcare centers may exclude unvaccinated students during outbreaks. Public health officials use testing, isolation, and contact tracing to limit spread—but prevention through vaccination is more effective than outbreak control alone.

How effective is the MMR vaccine?

According to CDC data:

One dose of MMR is about 93% effective at preventing measles.
Two doses are about 97% effective.

The routine U.S. schedule recommends:

First dose at 12–15 months
Second dose at 4–6 years

The vaccine has been used for decades and is monitored continuously for safety. Like all vaccines, it can cause mild side effects such as soreness or low fever. Serious reactions are rare.

What to do after exposure

If you think you or your child has been exposed to measles:

Call your healthcare provider before visiting so precautions can be arranged.
An MMR dose within 72 hours of exposure may prevent illness.
Immune globulin within 6 days may help protect high-risk individuals.

Seek urgent care for trouble breathing, severe dehydration, confusion, or seizures.

Why global vaccination matters at home

Measles anywhere can become measles everywhere. High vaccination coverage worldwide reduces the chance that travelers bring the virus into U.S. communities.

Public health experts emphasize that rebuilding routine childhood immunization systems—both in the United States and globally—is central to preventing larger outbreaks.

What this means for families now

Check your family’s vaccination records.
If traveling internationally, confirm you are fully vaccinated.
If fever and rash develop, stay home and call ahead before seeking care.
Understand that strong local vaccination coverage protects infants, pregnant people, and immunocompromised neighbors.

Measles is preventable—but only if communities maintain high vaccination rates. The global surge in 2026 is a reminder that public health progress can reverse when coverage slips, and that prevention at home depends on prevention worldwide.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.